Citigroup’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $24.5K | Sell |
|
|||||
|
2025
Q2 | $45.9K | Sell |
|
|||||
|
2025
Q1 | $44.7K | Sell |
|
|||||
|
2024
Q4 | $78.9K | Buy |
|
|||||
|
2024
Q3 | $141K | Buy |
|
|||||
|
2024
Q2 | $55.7K | Buy |
|
|||||
|
2024
Q1 | $42.1K | Sell |
|
|||||
|
2023
Q4 | $344K | Buy |
|
|||||
|
2023
Q3 | $39.3K | Buy |
|
|||||
|
2023
Q2 | $76.7K | Buy |
|
|||||
|
2023
Q1 | $9.83K | Sell |
|
|||||
|
2022
Q4 | $8.05K | Sell |
|
|||||
|
2022
Q3 | $11K | Sell |
|
|||||
|
2022
Q2 | $31K | Buy |
|
|||||
|
2022
Q1 | $18K | Sell |
|
|||||
|
2021
Q4 | $93K | Buy |
|
|||||
|
2021
Q3 | $43K | Sell |
|
|||||
|
2021
Q2 | $53K | Buy |
|
|||||
|
2021
Q1 | $20K | Sell |
|
|||||
|
2020
Q4 | $314K | Sell |
|
|||||
|
2020
Q3 | $150K | Buy |
|
|||||
|
2020
Q2 | $24K | Sell |
|
|||||
|
2020
Q1 | $36K | Buy |
|
|||||
|
2019
Q4 | $74K | Sell |
|
|||||
|
2019
Q3 | $146K | Sell |
|
|||||
|
2019
Q2 | $895K | Buy |
|
|||||
|
2019
Q1 | $626K | Sell |
|
|||||
|
2018
Q4 | $2.64M | Buy |
|
|||||
|
2018
Q3 | $2.86M | Buy |
|
|||||
|
2018
Q2 | $2.02M | Buy |
|
|||||
|
2018
Q1 | $513K | Sell |
|
|||||
|
2017
Q4 | $770K | Buy |
|
|||||
|
2017
Q3 | $899K | Buy |
|
|||||
|
2017
Q2 | $723K | Buy |
|
|||||
|
2017
Q1 | $604K | Sell |
|
|||||
|
2016
Q4 | $2.09M | Buy |
|
|||||
|
2016
Q3 | $483K | Buy |
|
|||||
|
2016
Q2 | $196K | Sell |
|
|||||
|
2016
Q1 | $508K | Buy |
|
|||||
|
2015
Q4 | $80K | Sell |
|
|||||
|
2015
Q3 | $550K | Buy |
|
|||||
|
2015
Q2 | $119K | Sell |
|
|||||
|
2015
Q1 | $106K | Sell |
|
|||||
|
2014
Q4 | $139K | Buy |
|
|||||
|
2014
Q3 | $40K | Sell |
|
|||||
|
2014
Q2 | $48K | Sell |
|
|||||
|
2014
Q1 | $198K | Buy |
|
|||||
|
2013
Q4 | $202K | Buy |
|
|||||
|
2013
Q3 | $244K | Buy |
|
|||||
|
2013
Q2 | $40K | Buy |
|